We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current RTGN market cap is 115.06M. The company's latest EPS is USD -0.1156 and P/E is -55.02.
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -2.18M | -3.91M | -2.09M |
| Net Income | -2.18M | -3.91M | -2.09M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5k | 0 | 0 |
| Total Liabilities | 470k | 1.07M | 1.41M |
| Total Equity | -465k | -1.07M | -1.41M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.17M | -200k | -348k |
| Investing | N/A | N/A | N/A |
| Financing | 1.17M | 195k | 348k |
| Market Cap | 115.06M |
| Price to Earnings Ratio | -55.02 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | -81.83 |
| Dividend Yield | - |
| Shares Outstanding | 18.09M |
| Average Volume (1 week) | 500 |
| Average Volume (1 Month) | 300 |
| 52 Week Change | 105.16% |
| 52 Week High | 6.36 |
| 52 Week Low | 0.25 |
| Spread (Intraday) | 52.38 (97%) |
| Company Name | Retinalgenix Technologies Inc (QB) |
| Address |
16192 coastal hwy lewes, delaware 19958 |
| Website | https://www.retinalgenix.com. |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
